4.5 Review

The Microtubule-Associated Protein Tau is Also Phosphorylated on Tyrosine

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 18, 期 1, 页码 1-9

出版社

IOS PRESS
DOI: 10.3233/JAD-2009-1116

关键词

Alzheimer's disease; c-Abl; Fyn; Lck; Src; Syk; tau; tauopathies; tyrosine phosphorylation

资金

  1. Medical Research Council [G0700355, G0300408] Funding Source: Medline
  2. MRC [G0700355, G0300408] Funding Source: UKRI

向作者/读者索取更多资源

Tau protein is the principal component of the neurofibrillary tangles found in Alzheimer's disease (AD), where it is hyperphosphorylated on serine and threonine residues. It is hypothesized that this hyperphosphorylation contributes to neurodegeneration through the destabilization of microtubules. There is now evidence that phosphorylation of tau can also occur on tyrosine residues. Human tau has five tyrosines numbered 18, 29, 197, 310, and 394, according to the sequence of the longest CNS isoform. Tyrosines 18, 197, and 394 have been shown to be phosphorylated in the brain of patients with AD whereas tyrosine 394 is the only residue that has been described to date that is phosphorylated in physiological conditions. Src family kinases and spleen tyrosine kinase (Syk) have been shown to phosphorylate tyrosine 18 while c-Abl is capable of phosphorylating tyrosine 394. Recently, a dual specificity kinase termed TTBK1 has been characterized in human brain and shown to be able to phosphorylate residue 197 of tau. Data about the role of tau tyrosine phosphorylation in neuronal physiology are still scarce and preliminary. In contrast, there is mounting evidence suggesting that tau tyrosine phosphorylation is an early event in the pathophysiology of AD and that Fyn and c-Abl are critical in the neurodegenerative process which occurs in tauopathies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Astrocyte-microglial association and matrix composition are common events in the natural history of primary familial brain calcification

Khayrun Nahar, Thibaud Lebouvier, Maarja Andaloussi Mae, Anne Konzer, Jonas Bergquist, Yvette Zarb, Bengt Johansson, Christer Betsholtz, Michael Vanlandewijck

BRAIN PATHOLOGY (2020)

Article Biochemistry & Molecular Biology

Tau accumulates in Crohn's disease gut

Alice Prigent, Guillaume Chapelet, Adrien De Guilliem de Lataillade, Thibauld Outlier, Emilie Durieu, Arnaud Bourreille, Emilie Duchalais, Kevin Hardonniere, Michel Neunlist, Wendy Noble, Saadia Kercline-Romer, Pascal Derkinderen, Malvyne Rolli-Derkinderen

FASEB JOURNAL (2020)

Review Pharmacology & Pharmacy

Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets

Israel Olapeju Bolanle, Kirsten Riches-Suman, Ritchie Williamson, Timothy M. Palmer

Summary: Protein O-GlcNAcylation has emerged as a new mechanism in the pathogenesis of cardiovascular diseases, playing a vital role in modulating vascular homeostasis and cardiac function through altering cellular functions of target proteins. Studying this mechanism may provide new therapeutic targets for the development of more effective medicines.

PHARMACOLOGICAL RESEARCH (2021)

Article Cell Biology

The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression

Dan Wu, Sailan Wang, Daniel V. Oliveira, Francesca Del Gaudio, Michael Vanlandewijck, Thibaud Lebouvier, Christer Betsholtz, Jian Zhao, ShaoBo Jin, Urban Lendahl, Helena Karlstrom

Summary: Infantile myofibromatosis (IMF) is a benign tumor characterized by nonmetastatic tumors, with some cases associated with NOTCH3 gene mutations. Specifically, the NOTCH3L1519P mutation leads to enhanced downstream signaling but absence from the cell surface, instead accumulating in the endoplasmic reticulum. Treatment with chloroquine reduces secreted mutated extracellular domain and decreases signaling, while NOTCH3L1519P also upregulates PDGFRB expression in fibroblasts.

DISEASE MODELS & MECHANISMS (2021)

Review Biochemistry & Molecular Biology

Tau in the gut, does it really matter?

Pascal Derkinderen, Malvyne Rolli-Derkinderen, Guillaume Chapelet, Michel Neunlist, Wendy Noble

Summary: The enteric nervous system, often referred to as the 'second brain', shares many features with the central nervous system and may be susceptible to neurodegenerative diseases similar to those affecting the brain. Current studies focus on the expression and phosphorylation pattern of tau protein in the enteric nervous system, exploring the potential occurrence of 'enteric tauopathies'.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Cardiac & Cardiovascular Systems

Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylation

Israel O. Bolanle, Kirsten Riches-Suman, Mahmoud Loubani, Ritchie Williamson, Timothy M. Palmer

Summary: Coronary artery bypass graft (CABG) using autologous saphenous vein remains the gold standard for treating CAD patients, but those with T2DM are at higher risk of graft failure. Protein O-GlcNAcylation has emerged as a key mechanism in the pathogenesis of vein graft failure in T2DM, providing potential therapeutic targets for new drug development.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)

Article Biochemistry & Molecular Biology

Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2

Erica Staurenghi, Valentina Cerrato, Paola Gamba, Gabriella Testa, Serena Giannelli, Valerio Leoni, Claudio Caccia, Annalisa Buffo, Wendy Noble, Beatriz Gomez Perez-Nievas, Gabriella Leonarduzzi

Summary: Among the brain hallmarks of Alzheimer's disease, reactive astrocytes are correlated with neuronal loss and cognitive deficits, while alterations in brain cholesterol metabolism contribute to AD pathogenesis. Oxysterols in AD brains induce astrocyte reactivity and the release of mediators that impact neuronal health and synapses, with lipocalin-2 playing a key role in mediating the synaptotoxic effect of oxysterol-treated astrocytes.

REDOX BIOLOGY (2021)

Article Cell Biology

Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia

Patricia Gomez-Suaga, Gabor M. Morotz, Andrea Markovinovic, Sandra M. Martin-Guerrero, Elisavet Preza, Natalia Arias, Keith Mayl, Afra Aabdien, Vesela Gesheva, Agnes Nishimura, Ambra Annibali, Younbok Lee, Jacqueline C. Mitchell, Selina Wray, Christopher Shaw, Wendy Noble, Christopher C. J. Miller

Summary: This study reveals that hexanucieotide repeat expansions in C9orf72 disrupt the ER-mitochondria signalling and VAPB-PTPIP51 tethers, leading to neurotoxicity. The interaction between VAPB-PTPIP51 is disrupted by neurotoxic DPRs, potentially involving the activation of GSK3β. Furthermore, these DPRs also disrupt the delivery of Ca2+ from ER stores to mitochondria, which is a primary function of the VAPB-PTPIP51 tethers. These findings identify a new molecular target for mutant C9orf72-mediated toxicity.

AGING CELL (2022)

Article Immunology

Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity

Beatriz G. Perez-Nievas, Louisa Johnson, Paula Beltran-Lobo, Martina M. Hughes, Luciana Gammallieri, Francesca Tarsitano, Monika A. Myszczynska, Irina Vazquez-Villasenor, Maria Jimenez-Sanchez, Claire Troakes, Stephen B. Wharton, Laura Ferraiuolo, Wendy Noble

Summary: The pathological interactions between beta-amyloid (A beta) and tau contribute to synapse loss and cognitive decline in Alzheimer's disease (AD). Reactive astrocytes play a prominent role in AD brain and exacerbate the synaptotoxic effects of A beta through the interaction of astrocytic CXCL1 and neuronal CXCR2 receptors, suggesting a potential novel therapeutic target.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Biochemistry & Molecular Biology

The Disease Associated Tau35 Fragment has an Increased Propensity to Aggregate Compared to Full-Length Tau

Chen Lyu, Stefano Da Vela, Youssra Al-Hilaly, Karen E. Marshall, Richard Thorogate, Dmitri Svergun, Louise C. Serpell, Annalisa Pastore, Diane P. Hanger

Summary: Tau35 is a truncated form of tau found in human brain in certain tauopathies, and its expression in mice recapitulates key features of human disease including increased tau phosphorylation and cognitive/motor dysfunction. Structural characterization revealed that Tau35 exhibits higher rigidity and a higher propensity to aggregate compared to longer tau isoforms 2N3R and 2N4R. Tau35 aggregates are morphologically similar to previously reported tau fibrils but more densely packed, shedding light on their potentially damaging role in tauopathies.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Clinical Neurology

Interoception and social cognition in chronic low back pain: a common inference disturbance? An exploratory study

Florent El Grabli, Francois Quesque, Celine Borg, Michael Witthoeft, George A. Michael, Christian Lucas, Florence Pasquier, Thibaud Lebouvier, Maxime Bertoux

Summary: This study found that patients with chronic low back pain have lower interoceptive accuracy and mentalizing abilities, but there was no correlation between these performances.

PAIN MANAGEMENT (2021)

Article Clinical Neurology

A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging

Julien Dumurgier, Severine Sabia, Henrik Zetterberg, Charlotte E. Teunissen, Bernard Hanseeuw, Adelina Orellana, Susanna Schraen, Audrey Gabelle, Merce Boada, Thibaud Lebouvier, Eline A. J. Willemse, Emmanuel Cognat, Agustin Ruiz, Claire Hourregue, Matthieu Lilamand, Elodie Bouaziz-Amar, Jean-Louis Laplanche, Sylvain Lehmann, Florence Pasquier, Philip Scheltens, Kaj Blennow, Archana Singh-Manoux, Claire Paquet

Summary: This study proposes a new algorithm to establish cutoffs for CSF biomarkers of Alzheimer's disease (AD) and validates it against CSF classification derived from PET imaging. The algorithm shows high agreement with the PET imaging-based classification and can potentially reduce heterogeneity in AD classification.

NEUROLOGY (2022)

Article Clinical Neurology

Investigating key factors underlying neurodegeneration linked to alpha-synuclein spread

Cindy C. C. Pang, Maja H. Sorensen, Krit Lee, Kelvin C. Luk, John Q. Trojanowski, Virginia M. Y. Lee, Wendy Noble, Raymond C. C. Chang

Summary: This study investigates the role of pathological alpha-synuclein in Parkinson's disease. The results suggest that spread/replication of pathological aSyn may not be sufficient to induce neurodegenerative changes. Instead, oxidative stress responses and aSyn accumulation are associated with other Parkinson's disease-associated abnormalities and cognitive dysfunction.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Review Biochemistry & Molecular Biology

Astrocyte adaptation in Alzheimer's disease: a focus on astrocytic P2X7R

Paula Beltran-Lobo, Matthew J. Reid, Maria Jimenez-Sanchez, Alexei Verkhratsky, Beatriz G. Perez-Nievas, Wendy Noble

Summary: Astrocytes play important roles in maintaining the balance and defense of the central nervous system. In Alzheimer's disease, astrocytes undergo various changes and are closely associated with abnormal protein aggregates. This review focuses on the P2X7 receptor and its contribution to altered astrocyte functions in Alzheimer's disease. Animal studies have shown that targeting P2X7 receptor can improve cognitive and synaptic impairments in models of the disease.

ESSAYS IN BIOCHEMISTRY (2023)

Review Clinical Neurology

Artificial intelligence for neurodegenerative experimental models

Sarah J. Marzi, Brian M. Schilder, Alexi Nott, Carlo Sala Frigerio, Sandrine Willaime-Morawek, Magda Bucholc, Diane P. Hanger, Charlotte James, Patrick A. Lewis, Ilianna Lourida, Wendy Noble, Francisco Rodriguez-Algarra, Jalil-Ahmad Sharif, Maria Tsalenchuk, Laura M. Winchester, Umran Yaman, Zhi Yao, Janice M. Ranson, David J. Llewellyn

Summary: This article reviews the application of artificial intelligence (AI) and machine learning (ML) in dementia research. The challenges of reproducibility and cross-species translation are discussed, and the potential of AI and ML methods to enhance research and translation is evaluated. Data resources and AI approaches are highlighted as solutions, and the exciting future possibilities of multi-omics analysis with AI in drug discovery are mentioned.

ALZHEIMERS & DEMENTIA (2023)

暂无数据